Fact Source: Financial Supervisory Service DART / 2024-11-27
Disclosure Type: Sales / Supply Contract
💡 Summary in 3 Seconds
Hanwha Systems has signed a supply contract worth KRW 61.59B (excl. VAT / 2.51% of 2023 revenue) with Korea Aerospace Industries, Ltd. for ‘MC, MFD, ACCS, IRST’ under the KF-21 Initial Mass Production Project through December 30, 2026.
📊 1. [Key Disclosure Details & Financial Highlights]
- Contract Name: MC, MFD, ACCS, IRST
- Project Category: KF-21 Initial Mass Production Project
- Contract Amount: KRW 61,589,705,110 (VAT excluded / approx. KRW 61.59B)
- Relative Size to Revenue: 2.51% (Based on 2023 consolidated annual revenue of KRW 2.45T)
- Counterparty: Korea Aerospace Industries, Ltd.
- Supply Region: Domestic (Republic of Korea)
- Contract Period: November 26, 2024 ~ December 30, 2026 (approx. 2 years and 1 month)
- Contract Date: November 26, 2024
- Other Notes: Contract amount and duration remain subject to potential changes based on project progress.
📈 2. [Professional Insight: What This Means for Investors]
This filing details a sales and supply contract executed between Hanwha Systems and Korea Aerospace Industries, Ltd. The contract title specified in the filing is ‘MC, MFD, ACCS, IRST’, and notes clarify that this transaction is part of the ‘KF-21 Initial Mass Production Project’.
Financially, the contract value of KRW 61.59B (excl. VAT) corresponds to 2.51% of Hanwha Systems’ 2023 consolidated annual revenue (approx. KRW 2.45T). The contract spans approximately two years and one month, running from November 26, 2024 to December 30, 2026, with provisions noting that contract terms remain subject to potential adjustments based on project execution.
📝 Editor’s Comment (by K-STOCK Editor)
The objective fact established in this disclosure is that Hanwha Systems secured a KRW 61.59B (excl. VAT) contract with Korea Aerospace Industries, Ltd. for ‘MC, MFD, ACCS, IRST’ under the KF-21 initial mass production project, equivalent to 2.51% of its 2023 annual revenue.
Moving forward, the primary objective checkpoints for investors are tracking contract execution through the scheduled completion date of December 30, 2026, and monitoring for any subsequent regulatory amendment filings. As the disclosure explicitly states that terms may shift depending on progress, tracking implementation milestones remains the reference point.
📢 Disclaimer & Source Notice
Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
